3,4-methylenedioxyamphetamine has been researched along with Infant, Newborn, Diseases in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koop, CE | 1 |
| Stone, FH | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Infant, Newborn, Diseases
| Article | Year |
|---|---|
The Surgeon General's Workshop on Children with Handicaps and Their Families. Keynote address.
Topics: Child Development; Communication; Community Health Services; Disabled Persons; Family; Female; Human | 1983 |
Psychological aspects of early mother-infant relationships.
Topics: Attitude of Health Personnel; Child Abuse; Congenital Abnormalities; Crying; Depression; Female; Hum | 1971 |